All publications and patent applications mentioned in this specification are herein incorporated by reference in their entirety to the same extent as if each individual publication or patent application was specifically and individually indicated to be incorporated by reference.
The inventions described herein relate to the field of implantable neurostimulators.
Nerve cuffs (e.g., nerve cuff electrodes) may be used to apply energy to a nerve. For example, a nerve cuff electrode may have a plurality of segmented platinum contacts connected by at least one wire made of durable and biocompatible conductive material fashioned in a helical configuration. The nerve cuff electrode may include a plurality of conductive nerve contact segments, with the segments having an inner surface contacting a nerve trunk and an outer surface not contacting the nerve trunk; at least a single wire of a conductive biocompatible material operatively connecting the plurality of conductive nerve contact segments thus forming a segmented strip, the wire configured as helical portions separated by non-helical portions where the non-helical portions are secured to the surface of the conductive nerve contact segments not contacting the nerve trunk; and a conductive lead capable of operatively connecting a waveform generator to at least one of the plurality of nerve contact segments.
For example, the nerve cuffs described herein may be applied to relatively large nerve, i.e., a nerve with a diameter exceeding about 3 mm and up to 12 mm. The nerve cuff may include a self-curling sheet of non-conductive material that includes a first layer, which is pre-tensioned, and a second layer, which is not pre-tensioned. The two layers are configured to form a cuff containing or holding strips of conductive material there between. The device may have one, two, three, four or more segmented strips of a conductive material that are disposed adjacent, but not transverse, to one longitudinally extending edge of the self-curling sheet, each of these strips of conductive material may be connected to an electrically conductive lead. The nerve cuff may contain one strip of a conductive material, termed a monopolar configuration, or at least two segmented strips, connected by an electrically conductive lead, of a conductive material, termed a bipolar configuration. The nerve cuff may contain three segmented strips, connected by an electrically conductive lead, of a conductive material, termed a tripolar configuration, or at least four segmented strips, connected by an electrically conductive lead, of a conductive material. Multiple apertures, typically circular but not necessarily so limited in shape, may be disposed at periodic intervals of the inner nerve-contacting surface along the curling length of one of the two non-conductive sheets or layers of the self-curling sheet/cuff. This may provide contact to the nerve by exposing and providing continuous multiple conductive contact points. The exposure may be at any interval that exposes as much of the conductive material as possible or desirable, and exceeds the contact surface area of conventional electrodes. Each of the first or top non-conductive sheet or layer and the second or bottom non-conductive sheet or layer may still retain and contain the conductive material therebetween, i.e., sandwiched inside the sheets or layers, so that the conductive material is in fact retained and does not pop out or come out while providing efficient current delivery. The non-conductive material may be silicone, the electrically conductive lead may be stainless steel, and the conductive material may be platinum. Other materials for each of the non-conductive material, the electrically conductive lead or wire, and the conductive material are known in the art. In use, the device may be operatively connected, e.g., by an external lead or wire, to a waveform generator that provides the regulated waveform.
The wire helical portions may be arranged along the wire length between the conductive nerve contact segments, and the wire non-helical portions may be secured to the conductive nerve contact segments by a plurality of spot welds. The wire helical portions may be embedded in a non-conductive material. The helical portions may be separated by non-helical portions that connect the conductive nerve contact segments. A second wire may operatively connect the plurality of nerve contact segments, with the second wire generally parallel with the first wire. The conductive nerve contact segments may be platinum, the wires may be stainless steel, and the non-conductive material may be silicone.
For example,
The nerve cuffs described herein may encircle a particular segment of a targeted peripheral nerve, e.g., a sciatic nerve, a tibial nerve. Using a patient-implanted electrode connected to an electrical waveform generator, an electrical waveform may be applied for a time interval, e.g., 10 min, sufficient to effect substantially immediate patient pain relief, e.g., within 10 min, and an extended period of pain relief up to several hours. The current may range, for example, from 4 mApp to 26 mApp. In general, electrical nerve block or activation in patients for pain management or other conditions may require a direct interfacing device with peripheral nerves in the form of a cuff wrapping around a nerve trunk. For example, U.S. Pat. No. 8,731,676 discloses a bipolar nerve cuff electrode with two continuous platinum strips embedded in a silicone substrate used to wrap around a nerve trunk. However, breakage of the platinum strips was found where a larger nerve trunk and/or certain anatomical characteristics (such as short stumps in above-knee amputees) were encountered. Inspections of explanted electrodes revealed that the platinum strips situated around the nerve trunk were wrinkled/creased or broken along their length due to repeated bending when the nerve trunk was compressed and flattened during daily activities. Platinum has a low mechanical strength despite its superior biocompatibility and electrical characteristics for charge delivery, thus, it may be beneficial to use multiple segmented platinum contacts, each segment connected with wires made of a durable and biocompatible conductive material, e.g., stainless steel (SS). The total surface area of all of the platinum contacts may be equivalent to that of a continuous strip by increasing the width to compensate for the gaps between the contacts. The configuration of the wire interconnection may establish the durability and flexibility of the cuff electrode. For example, a 7-strand of 316LVM wire may be wound into a helix. A gap may be created along the helix wherever it overlaps with a platinum contact. Conventional spot welding may be used for connecting the wire to the platinum contact. Two wire helices lying in parallel may be employed to provide redundancy. The helices may be entirely embedded in the silicone sheeting and only the outer side of the platinum contacts was exposed to the surface of the nerve trunk.
In use, the application of 10 kHz alternating current generated by a custom generator via a custom implanted nerve electrode may significantly reduce pain in the majority of patients treated. For example, an implantable electrode operatively connected to an external or implanted waveform generator may be used. The electrode may be a spiral cuff electrode similar to that described in U.S. Pat. No. 4,602,624. The electrode may be implanted in a human mammal on a desired peripheral nerve trunk proximal to the pain source (e.g., a neuroma), such that the cuff encircled the desired peripheral nerve in which the action potential was to be blocked. The cuff inner diameter may range from about 5 mm to about 12 mm. The sciatic nerve is known to have a relatively large nerve trunk; the diameter of the proximal part of the sciatic nerve in a human adult is about 12 mm. In one embodiment, the apparatus and method was used on the sciatic nerve to treat limb pain in above knee amputees. In one embodiment, the apparatus and method was used on the tibial nerve to treat limb pain in below knee amputees.
For example,
Any reduction in the size of this access incision would be highly desirable. However, to date, because of the difficulty in accessing the nerve trunk of the amputee, only open procedures have been used. Described herein are methods and apparatuses (including systems and devices, which may specifically include access tools) for minimally invasively attaching a nerve cuff, and specifically nerve cuffs such as those described, e.g., in U.S. patent application no. US20170246453A1.
Described herein is a deployment device to introduce a nerve cuff electrode via minimal surgical incision, including a cannula accommodating, e.g., a 13 mm diameter. The nerve cuff electrode may be deployed via an apparatus such as an introducer tool which encapsulates the electrode (e.g., in some variations via a two-part compartment) and provides support for visualizing and positioning the nerve cuff, protecting the nerve cuff electrode, so that it can be implanted in the desired location in a minimally invasive manner.
In some variations, the introducer capsule is delivered and pushed through the cannula (e.g., trocar), once the nerve target is identified and exposed via the cannula. In any of these variations, endoscopic visualization may be used as part of the deployment; the delivery tool may couple with or integrate with an endoscope, or may be used separately from the endoscope. In some variations, the delivery tool may then be detached; for example, in variations including a two-part capsule, the capsule may be detached, and the electrode remains may be implanted near the target nerve site; the delivery tool (e.g., capsule) may then be removed from the cannula. The electrode may be unrolled via forceps, placed around the targeted nerve and sutured closed via two suture loops.
For example, described herein are methods of minimally-invasively attaching a nerve cuff electrode to a patient's nerve (e.g., nerve root). Any of these methods may include: minimally invasively inserting a cannula (which may be part of a trocar) into the patient's body (e.g., tissue) to a nerve root region; inserting a nerve cuff deployment tool into the cannula, wherein the nerve cuff electrode is attached at a distal end of an elongated body of the nerve cuff deployment tool, further wherein the elongated body of the nerve cuff deployment tool has a column strength sufficient to resist buckling at compressive forces of at least a predetermined amount (e.g., 2 N, 5 N, 10 N, 15 N, 20 N, 25 N, 30 N, etc.); advancing the nerve cuff deployment tool distally through the cannula into the nerve root region; and disengaging the nerve cuff from the nerve cuff deployment tool and coupling the nerve cuff to the patient's nerve root.
Any of these methods may also include visualizing the nerve root region. For example any of these methods may include inserting a visualization tool into the nerve root region and visualizing the nerve root region. The visualization tool (e.g., a scope) may be separate from the cannula, or it may be combined with/coupled to the cannula. For example, the visualization tool may include a cannula and may visualize the distal end of the cannula, e.g., near the nerve root region. The scope may include illumination. The scope may include a camera.
The cannula may be inserted as part of a trocar. For example, a trocar having a cutting portion (e.g., an obturator) and a cannula may also include a seal and may be minimally invasively inserted into the body as part of any of these methods. For example, minimally invasively inserting the cannula may include inserting a trocar through the patient's tissue to the nerve region, wherein the cannula forms a part of the trocar.
In general, the nerve root region includes a region around the nerve root onto which the nerve cuff electrode is to be positioned. The nerve root region may be proximal to neuroma (e.g., in an amputated region) and may include the nerve root and any surrounding tissues; alternatively or additionally the surrounding tissues may be removed (e.g., through the cannula) or retracted to create a clearing for insertion of the nerve cuff electrode.
Any of these methods may include removably attaching the nerve cuff electrode to the distal end of the elongated body of the nerve cuff deployment tool. For example, the nerve cuff electrode may be held within a chamber (e.g., capsule) of the nerve cuff deployment tool. Alternatively or additionally, the nerve cuff deployment tool may be connected by a clip, clamp, etc. to the nerve cuff electrode. The nerve cuff deployment tool may be configured to attach to a predetermined portion of the nerve cuff electrode; alternatively, the nerve cuff deployment tool may be configured to connected and hold to any region of the nerve cuff electrode. In some variations the nerve cuff deployment tool includes a nerve cuff engagement region that is configured to removably attach to the nerve cuff electrode. Examples of nerve cuff attachment or engagement regions are described below.
Any of the methods of operation described herein may include removably attaching the nerve cuff to the distal end of the nerve cuff deployment tool. This may include least partially enclosing the nerve cuff within a chamber of the nerve cuff deployment tool (e.g., within a sleeve, opening, cup, chamber, etc. of the nerve cuff deployment tool distal end, forming part of the nerve cuff engagement region. Alternatively, removably attaching the nerve cuff may comprise fully enclosing the nerve cuff, e.g., within a capsule region at a distal end of the nerve cuff deployment tool.
Inserting the nerve cuff deployment tool may include inserting the nerve cuff deployment tool with the nerve cuff attached wherein the nerve cuff is a self-rolling nerve cuff electrode. Self-rolling nerve cuffs as described, for example, in U.S. patent application Ser. No. 15/510,824, filed on Mar. 14, 2017, herein incorporated by reference in its entirety. The nerve cuff electrode may be held in a constrained (e.g., collapsed, constricted, etc.) configuration by the nerve cuff deployment tool.
The elongated body of the nerve cuff deployment tool may be flexible or rigid. In some variations, the nerve cuff deployment tool has a flexible elongated body (which still maintains sufficient column strength as indicated above), so as to navigate a bent or curved cannula for delivery.
Advancing the nerve cuff deployment tool distally through the cannula into the nerve root region may include positioning a distal end of the nerve cuff deployment tool adjacent to the nerve root within the nerve root region. For example, the distal end of the cannula may be positioned immediately adjacent to the nerve (e.g., within about 1 mm) or closely adjacent (e.g., within about 10 mm).
Disengaging the nerve cuff electrode from the nerve cuff deployment tool may include activating a detachment mechanism at the proximal end of the nerve cuff deployment tool. In some variations the nerve cuff electrode is disengaged by separating or opening two parts (e.g., halves) of a capsule to release the nerve cuff electrode; this may be done by proximally manipulating the nerve cuff deployment tool to separate the two portions forming the capsule, releasing the nerve cuff electrode and removing the portion of the nerve cuff deployment tool forming the capsule back into the catheter. For example, disengaging the nerve cuff from the nerve cuff deployment tool may include separating two halves of a nerve cuff capsule at the distal end of the nerve cuff deployment tool. In some variations a separate pusher is included having a distal end configured to apply distal force to the nerve cuff electrode. Thus, any of these methods may include pushing or holding the nerve cuff electrode using the pusher to separate or disengage the nerve cuff electrode from the rest of the nerve cuff deployment tool.
Either before, during or after disengaging the nerve cuff electrode from the nerve cuff deployment tool, the nerve cuff may be wrapped (e.g., rolled) around the nerve. For example, in some variations, the nerve cuff electrode may be wrapped around the nerve root when released from the nerve cuff deployment tool. The nerve cuff electrode may be held in an inverted configuration within the nerve cuff deployment tool, so that, when released from the nerve cuff deployment tool, it is biased to wrap itself around the nerve root; thus, the nerve cuff deployment tool may position the nerve cuff sufficiently near or adjacent to the nerve root so that it may automatically wrap itself around the nerve root. Alternatively or additionally, the nerve cuff electrode may be manipulated by, e.g., a laparoscopic or other tool (e.g., forceps, etc.) to position or wrap around the nerve root. For example, any of these methods may include extending one or more manipulators (e.g., pairs of manipulators) through the cannula to wrap the nerve cuff around the nerve root.
For example, a method of minimally-invasively attaching a nerve cuff electrode to a patient's nerve root may include: minimally invasively inserting a cannula the patient's tissue to a nerve root region; inserting a nerve cuff deployment tool into the cannula, wherein the nerve cuff electrode comprises a self-curling nerve cuff electrode that is removably attached at a distal end of an elongated body of the nerve cuff deployment tool, further wherein the elongated body of the nerve cuff deployment tool has a column strength sufficient to resist buckling at compressive forces of at least 10 N; advancing the nerve cuff deployment tool distally through the cannula into the nerve root region; and disengaging the nerve cuff from the nerve cuff deployment tool and wrapping the nerve cuff to the patient's nerve root.
In general, a nerve cuff deployment apparatus for minimally invasively attaching a nerve cuff electrode to a patient's nerve root may include: an elongated body having a column strength sufficient to resist buckling at compressive forces of at least some predetermined amount of force (e.g., 2 N, 3 N, 4 N, 5 N, 6 N, 7 N, 8 N, 9 N, 10 N, 12 N, 15 N, 20 N, 25 N, 30 N, etc.); and a nerve cuff engagement region at a distal end of elongated body, configured to releasably secure to a nerve cuff electrode.
Any of these systems may include the nerve cuff electrode as part of the system, which may be pre-loaded. For example, any of these systems may include a self-curling nerve cuff electrode, as described herein. Thus, the system may include a self-curling nerve cuff releasably coupled to the nerve cuff engagement region.
The elongated body may be flexible. In some variation, the elongated body is rigid.
In some variations the apparatus is configured to form an enclosure to hold the nerve cuff electrode. For example, the elongated body may include a first half and a second half, wherein the nerve cuff engagement region comprises a first capsule portion at the distal end of the first half and a second capsule portion at the distal end of the second half, wherein the first and second capsule portions are configured to couple to form a capsule to enclose and protect the nerve cuff electrode.
In some variation, the nerve cuff engagement region includes a flared-open distal-facing region chamber configured to at least partially enclose the nerve cuff electrode. Alternatively or additionally, the nerve cuff engagement region may include a hook or fork configured to releasably engage with the nerve cuff electrode. The nerve cuff engagement region may hold the expandable (curling) wings of the nerve cuff electrode or to the base of the nerve cuff electrode, e.g., where the wire(s) extending from the nerve cuff electrode extend proximally. In some variations, the nerve cuff engagement region comprises a rounded distal end configured to engage with the nerve cuff electrode. The rounded distal end may be configured to support against the nerve cuff electrode without damaging the nerve cuff electrode, e.g., by pushing against it. In some variations nerve cuff engagement region includes a passage for holding the lead extending from the nerve cuff.
As mentioned, any of these apparatuses may include a pusher (e.g., a nerve cuff pusher) extending adjacent to the elongated body and having a distal end configured to apply distal force to the nerve cuff electrode. The pusher may extend within the elongated body of the nerve cuff deployment apparatus. The distal-facing end of the pusher (the distal end) may be configured to engage with the nerve cuff electrode. For example, the distal-facing end of the pusher may include a forked distal end that is configured to engage with the nerve cuff electrode.
In any of these variations, the nerve cuff deployment apparatus may include a proximal control coupled to the elongated body configured to disengage the nerve cuff engagement region from the nerve cuff electrode. The proximal control may include a handle, grip, button, switch, slider, or the like. For example, the proximal control may be a handle coupled to a slider that allows the apparatus to engage with the pusher, for example, and/or the halves of the elongated body that can be (in some variations) separated to release the nerve cuff electrode.
For example, a nerve cuff deployment apparatus for minimally invasively attaching a nerve cuff electrode to a patient's nerve root may include: an elongated body having a column strength sufficient to resist buckling at compressive forces of at least 10 N, wherein the elongated body comprises a first half and a second half, each extending distally to proximally; and a nerve cuff engagement region at a distal end of elongated body, configured to releasably secure to a nerve cuff electrode, wherein the nerve cuff engagement region further comprises a first capsule portion at the distal end of the first half and a second capsule portion at the distal end of the second half, wherein the first and second capsule portions are configured to form a capsule to enclose and protect the nerve cuff electrode.
The novel features of the invention are set forth with particularity in the claims that follow. A better understanding of the features and advantages of the present invention will be obtained by reference to the following detailed description that sets forth illustrative embodiments, in which the principles of the invention are utilized, and the accompanying drawings of which:
FIGS. 7A1-7A2 show another example of a nerve cuff deployment tool that includes a flexible deployment tool having high column strength that may be releasably attached to the self-curling nerve cuff (as shown in FIG. 7A1) and used to push or pull the nerve cuff within a delivery cannula or trocar. FIG. 7A2 shows the tool unconnected to a nerve cuff.
FIGS. 7D1 and 7D2 show another example of a nerve cuff deployment tool that includes a flexible deployment tool having high column strength that may be releasably attached to the self-curling nerve cuff (as shown in
In general, described herein are methods and apparatuses, including in particular tools such as nerve cuff deployment tools and methods of using them, for minimally invasively attaching a nerve cuff to a nerve trunk. In particular, described herein are methods and apparatuses for delivering nerve cuff electrode (particularly self-rolling nerve cuff electrodes) through an elongated cannula or other elongated, minimally invasive channel for deployment at, near or on a nerve root. In general, a nerve cuff deployment apparatus for minimally invasively attaching a nerve cuff electrode to a patient's nerve root may have a sufficient column strength (e.g., a column strength sufficient to resist buckling at compressive forces of at least 2 N, 5 N, 7 N, 8 N, 9 N, 10 N, 15 N, etc.) so that it may support and protect the generally flexible and loose nerve cuff electrode prior to placing it on the nerve root. The nerve cuff deployment device generally includes a nerve cuff engagement region at a distal end of elongated body that is configured to releasably secure to a nerve cuff electrode to be delivered.
As already discussed above,
Although any appropriate nerve cuff may be used, in particular, the nerve cuff may be a self-wrapping nerve cuff, such as illustrated in
Described herein are methods of less invasively applying a nerve cuff electrode onto a nerve root, including methods of minimally invasively applying the nerve cuff electrode that do not require a large incision. For example,
In
FIGS. 7A1-7D2 illustrate other variations of nerve cuff deployment tools that may be used with any of the methods descried herein. Elements from any of the nerve cuff deployment tools shown in any of the variations and embodiments described may be used with any of other variation or embodiment of a nerve cuff deployment tool. For example, a pusher such as the one shown in
FIG. 7A1 shows a nerve cuff deployment tool 715 releasably coupled to a nerve cuff electrode 717. In this example, the nerve cuff deployment tool has a bifurcated end 716 (e.g., forked or split) that may couple and engage with the nerve cuff electrode, and particularly the wrapping arms of the nerve cuff electrode. In some variations one or both arms may be hinged so as to close (e.g., clamp) onto each other to releasably secure the nerve cuff assembly between them; a control (e.g., handle, etc. on the distal end of the nerve cuff deployment tool may be operated to release the arms of the nerve cuff deployment tool. FIG. 7A2 shows a perspective view of the nerve cuff deployment tool not coupled to the nerve cuff.
FIGS. 7D1 and 7D2 show another example of a nerve cuff deployment tool 725 in which the nerve cuff engagement region 736 at the distal end of the nerve cuff deployment tool is configured to releasably couple with the nerve cuff electrode 717. This variation is similar to that shown in FIGS. 7A1-7A2, but may extend over the distal side of the nerve cuff electrode, allowing it to be both pulled and pushed robustly. This variations may also include a release, e.g., at the proximal end, and the distal end region may be hinged in one or more positions to remove the connection to the nerve cuff electrode. Alternatively, in some variations a pusher such as that shown in
Although in general, the nerve cuff electrodes described herein are similar to those shown in
Any of the methods (including user interfaces) described herein may be implemented as software, hardware or firmware, and may be described as a non-transitory computer-readable storage medium storing a set of instructions capable of being executed by a processor (e.g., computer, tablet, smartphone, etc.), that when executed by the processor causes the processor to perform any of the steps, including but not limited to: displaying, communicating with the user, analyzing, modifying parameters (including timing, frequency, intensity, etc.), determining, alerting, or the like.
When a feature or element is herein referred to as being “on” another feature or element, it can be directly on the other feature or element or intervening features and/or elements may also be present. In contrast, when a feature or element is referred to as being “directly on” another feature or element, there are no intervening features or elements present. It will also be understood that, when a feature or element is referred to as being “connected”, “attached” or “coupled” to another feature or element, it can be directly connected, attached or coupled to the other feature or element or intervening features or elements may be present. In contrast, when a feature or element is referred to as being “directly connected”, “directly attached” or “directly coupled” to another feature or element, there are no intervening features or elements present. Although described or shown with respect to one embodiment, the features and elements so described or shown can apply to other embodiments. It will also be appreciated by those of skill in the art that references to a structure or feature that is disposed “adjacent” another feature may have portions that overlap or underlie the adjacent feature.
Terminology used herein is for the purpose of describing particular embodiments only and is not intended to be limiting of the invention. For example, as used herein, the singular forms “a”, “an” and “the” are intended to include the plural forms as well, unless the context clearly indicates otherwise. It will be further understood that the terms “comprises” and/or “comprising,” when used in this specification, specify the presence of stated features, steps, operations, elements, and/or components, but do not preclude the presence or addition of one or more other features, steps, operations, elements, components, and/or groups thereof. As used herein, the term “and/or” includes any and all combinations of one or more of the associated listed items and may be abbreviated as “/”.
Spatially relative terms, such as “under”, “below”, “lower”, “over”, “upper” and the like, may be used herein for ease of description to describe one element or feature's relationship to another element(s) or feature(s) as illustrated in the figures. It will be understood that the spatially relative terms are intended to encompass different orientations of the device in use or operation in addition to the orientation depicted in the figures. For example, if a device in the figures is inverted, elements described as “under” or “beneath” other elements or features would then be oriented “over” the other elements or features. Thus, the exemplary term “under” can encompass both an orientation of over and under. The device may be otherwise oriented (rotated 90 degrees or at other orientations) and the spatially relative descriptors used herein interpreted accordingly. Similarly, the terms “upwardly”, “downwardly”, “vertical”, “horizontal” and the like are used herein for the purpose of explanation only unless specifically indicated otherwise.
Although the terms “first” and “second” may be used herein to describe various features/elements (including steps), these features/elements should not be limited by these terms, unless the context indicates otherwise. These terms may be used to distinguish one feature/element from another feature/element. Thus, a first feature/element discussed below could be termed a second feature/element, and similarly, a second feature/element discussed below could be termed a first feature/element without departing from the teachings of the present invention.
Throughout this specification and the claims which follow, unless the context requires otherwise, the word “comprise”, and variations such as “comprises” and “comprising” means various components can be co-jointly employed in the methods and articles (e.g., compositions and apparatuses including device and methods). For example, the term “comprising” will be understood to imply the inclusion of any stated elements or steps but not the exclusion of any other elements or steps.
In general, any of the apparatuses and methods described herein should be understood to be inclusive, but all or a sub-set of the components and/or steps may alternatively be exclusive, and may be expressed as “consisting of” or alternatively “consisting essentially of” the various components, steps, sub-components or sub-steps.
As used herein in the specification and claims, including as used in the examples and unless otherwise expressly specified, all numbers may be read as if prefaced by the word “about” or “approximately,” even if the term does not expressly appear. The phrase “about” or “approximately” may be used when describing magnitude and/or position to indicate that the value and/or position described is within a reasonable expected range of values and/or positions. For example, a numeric value may have a value that is +/−0.1% of the stated value (or range of values), +/−1% of the stated value (or range of values), +/−2% of the stated value (or range of values), +/−5% of the stated value (or range of values), +/−10% of the stated value (or range of values), etc. Any numerical values given herein should also be understood to include about or approximately that value, unless the context indicates otherwise. For example, if the value “10” is disclosed, then “about 10” is also disclosed. Any numerical range recited herein is intended to include all sub-ranges subsumed therein. It is also understood that when a value is disclosed that “less than or equal to” the value, “greater than or equal to the value” and possible ranges between values are also disclosed, as appropriately understood by the skilled artisan. For example, if the value “X” is disclosed the “less than or equal to X” as well as “greater than or equal to X” (e.g., where X is a numerical value) is also disclosed. It is also understood that the throughout the application, data is provided in a number of different formats, and that this data, represents endpoints and starting points, and ranges for any combination of the data points. For example, if a particular data point “10” and a particular data point “15” are disclosed, it is understood that greater than, greater than or equal to, less than, less than or equal to, and equal to 10 and 15 are considered disclosed as well as between 10 and 15. It is also understood that each unit between two particular units are also disclosed. For example, if 10 and 15 are disclosed, then 11, 12, 13, and 14 are also disclosed.
Although various illustrative embodiments are described above, any of a number of changes may be made to various embodiments without departing from the scope of the invention as described by the claims. For example, the order in which various described method steps are performed may often be changed in alternative embodiments, and in other alternative embodiments one or more method steps may be skipped altogether. Optional features of various device and system embodiments may be included in some embodiments and not in others. Therefore, the foregoing description is provided primarily for exemplary purposes and should not be interpreted to limit the scope of the invention as it is set forth in the claims.
The examples and illustrations included herein show, by way of illustration and not of limitation, specific embodiments in which the subject matter may be practiced. As mentioned, other embodiments may be utilized and derived there from, such that structural and logical substitutions and changes may be made without departing from the scope of this disclosure. Such embodiments of the inventive subject matter may be referred to herein individually or collectively by the term “invention” merely for convenience and without intending to voluntarily limit the scope of this application to any single invention or inventive concept, if more than one is, in fact, disclosed. Thus, although specific embodiments have been illustrated and described herein, any arrangement calculated to achieve the same purpose may be substituted for the specific embodiments shown. This disclosure is intended to cover any and all adaptations or variations of various embodiments. Combinations of the above embodiments, and other embodiments not specifically described herein, will be apparent to those of skill in the art upon reviewing the above description.
This patent application is a continuation of U.S. patent application Ser. No. 16/954,049, filed on Jun. 15, 2020, titled “NERVE CUFF DEPLOYMENT DEVICES,” now U.S. Publication No. US-2021-0008366-A1, which is a U.S. National Phase Application Under 35 U.S.C. § 371 of International Application No. PCT/US2018/065447, filed on Dec. 13, 2018, titled “NERVE CUFF DEPLOYMENT DEVICES,” now PCT Publication No. WO 2019/118725, which claims priority to U.S. Provisional Patent Application No. 62/598,369, filed on Dec. 13, 2017, titled “NERVE CUFF DEPLOYMENT DEVICES,” each of which is herein incorporated by reference in its entirety. This patent may also be related to pending U.S. patent application Ser. No. 15/510,824, filed on Mar. 14, 2017, and herein incorporated by reference in its entirety.
Number | Name | Date | Kind |
---|---|---|---|
3738368 | Avery et al. | Jun 1973 | A |
4155366 | Di Mucci | May 1979 | A |
4573481 | Bullara | Mar 1986 | A |
4602624 | Naples et al. | Jul 1986 | A |
4979511 | Terry | Dec 1990 | A |
5143067 | Rise et al. | Sep 1992 | A |
5324322 | Grill et al. | Jun 1994 | A |
5653739 | Maurer et al. | Aug 1997 | A |
5755750 | Petruska et al. | May 1998 | A |
5964702 | Grill, Jr. et al. | Oct 1999 | A |
6058331 | King | May 2000 | A |
6275735 | Jarding et al. | Aug 2001 | B1 |
6292703 | Meier et al. | Sep 2001 | B1 |
6456866 | Tyler et al. | Sep 2002 | B1 |
6699275 | Knudson et al. | Mar 2004 | B1 |
6735475 | Whitehurst et al. | May 2004 | B1 |
6760626 | Boveja | Jul 2004 | B1 |
6836685 | Fitz | Dec 2004 | B1 |
6860851 | Knudson et al. | Mar 2005 | B2 |
6871099 | Whitehurst et al. | Mar 2005 | B1 |
7076307 | Boveja et al. | Jul 2006 | B2 |
7167750 | Knudson et al. | Jan 2007 | B2 |
7201757 | Knudson et al. | Apr 2007 | B2 |
7292890 | Whitehurst et al. | Nov 2007 | B2 |
7295876 | Erickson | Nov 2007 | B1 |
7302296 | Hoffer | Nov 2007 | B1 |
7324852 | Barolat et al. | Jan 2008 | B2 |
7389145 | Kilgore et al. | Jun 2008 | B2 |
7444183 | Knudson et al. | Oct 2008 | B2 |
7463927 | Chaouat | Dec 2008 | B1 |
7489966 | Leinders et al. | Feb 2009 | B2 |
7555345 | Wahlstrand et al. | Jun 2009 | B2 |
7616990 | Chavan et al. | Nov 2009 | B2 |
7761166 | Giftakis et al. | Jul 2010 | B2 |
7839415 | Hillard et al. | Nov 2010 | B2 |
7860570 | Whitehurst et al. | Dec 2010 | B2 |
7894905 | Pless et al. | Feb 2011 | B2 |
7894906 | Shuros | Feb 2011 | B2 |
7979131 | Feler et al. | Jul 2011 | B2 |
8027718 | Spinner et al. | Sep 2011 | B2 |
8060208 | Kilgore et al. | Nov 2011 | B2 |
8060209 | Jaax et al. | Nov 2011 | B2 |
8108052 | Boling | Jan 2012 | B2 |
8116882 | Kowalczewski | Feb 2012 | B2 |
8170675 | Alataris et al. | May 2012 | B2 |
8185207 | Molnar et al. | May 2012 | B2 |
8219202 | Giftakis et al. | Jul 2012 | B2 |
8224453 | De Ridder | Jul 2012 | B2 |
8380318 | Kishawi et al. | Feb 2013 | B2 |
8452417 | Navarro | May 2013 | B2 |
8467879 | Whitehurst et al. | Jun 2013 | B1 |
8498711 | Roche | Jul 2013 | B2 |
8504147 | Deem et al. | Aug 2013 | B2 |
8521291 | Cholette et al. | Aug 2013 | B1 |
8560075 | Covalin | Oct 2013 | B2 |
8594796 | Roche | Nov 2013 | B2 |
8600505 | Libbus et al. | Dec 2013 | B2 |
8676329 | Wacnik et al. | Mar 2014 | B2 |
8676331 | Parker | Mar 2014 | B2 |
8712547 | Whitehurst et al. | Apr 2014 | B2 |
8731676 | Fang et al. | May 2014 | B2 |
8738140 | De Ridder | May 2014 | B2 |
8755893 | Gross et al. | Jun 2014 | B2 |
8761892 | Weisgarber et al. | Jun 2014 | B2 |
8788045 | Gross et al. | Jul 2014 | B2 |
8805518 | King et al. | Aug 2014 | B2 |
8903502 | Perryman et al. | Dec 2014 | B2 |
8923975 | Bradley | Dec 2014 | B2 |
8965516 | Bennett et al. | Feb 2015 | B2 |
8977362 | Saab | Mar 2015 | B2 |
8983612 | Fang et al. | Mar 2015 | B2 |
8983614 | Kilgore et al. | Mar 2015 | B2 |
9031658 | Chiao et al. | May 2015 | B2 |
9037248 | Durand et al. | May 2015 | B2 |
9089700 | Hlavka et al. | Jul 2015 | B2 |
9095699 | Rosenberg et al. | Aug 2015 | B2 |
9132272 | Alves et al. | Sep 2015 | B2 |
9259575 | Zhao et al. | Feb 2016 | B2 |
9295840 | Thacker et al. | Mar 2016 | B1 |
9295841 | Fang et al. | Mar 2016 | B2 |
9327121 | Thacker et al. | May 2016 | B2 |
9339655 | Carbunaru | May 2016 | B2 |
9387325 | Min et al. | Jul 2016 | B1 |
9403008 | Howard | Aug 2016 | B2 |
9403014 | Kilgore et al. | Aug 2016 | B2 |
9409019 | Walker et al. | Aug 2016 | B2 |
9421372 | Mashiach et al. | Aug 2016 | B2 |
9604062 | Carroll | Mar 2017 | B2 |
9630011 | Lipani | Apr 2017 | B2 |
9694181 | Bhadra et al. | Jul 2017 | B2 |
9814881 | Moffitt | Nov 2017 | B2 |
9884189 | Boggs | Feb 2018 | B2 |
9884192 | Kilgore et al. | Feb 2018 | B2 |
9889293 | Siegel et al. | Feb 2018 | B2 |
9931510 | Hou et al. | Apr 2018 | B2 |
9937348 | Bradley | Apr 2018 | B1 |
9956398 | Callegari et al. | May 2018 | B2 |
10086201 | Chang et al. | Oct 2018 | B2 |
10105541 | Kishawi et al. | Oct 2018 | B2 |
10149978 | Park | Dec 2018 | B1 |
10159838 | Kim et al. | Dec 2018 | B2 |
10195434 | Bhadra et al. | Feb 2019 | B2 |
10238872 | Pivonka et al. | Mar 2019 | B2 |
10258805 | Reed et al. | Apr 2019 | B2 |
10286213 | Fletcher et al. | May 2019 | B2 |
10300273 | Rooney et al. | May 2019 | B2 |
10315034 | Hou et al. | Jun 2019 | B2 |
10328256 | Gliner | Jun 2019 | B1 |
10390877 | Heggeness et al. | Aug 2019 | B2 |
10456575 | Kilgore et al. | Oct 2019 | B2 |
10617870 | Kilgore et al. | Apr 2020 | B2 |
10632309 | McGee et al. | Apr 2020 | B2 |
10675469 | Annoni et al. | Jun 2020 | B2 |
10722703 | Mitchell | Jul 2020 | B2 |
10758723 | Fang et al. | Sep 2020 | B2 |
10780270 | Schepis et al. | Sep 2020 | B2 |
10799701 | Lee | Oct 2020 | B2 |
10828491 | Schepis et al. | Nov 2020 | B2 |
10864373 | Bhadra et al. | Dec 2020 | B2 |
10894159 | De Ridder | Jan 2021 | B2 |
10926092 | Esteller et al. | Feb 2021 | B2 |
10953228 | Perryman et al. | Mar 2021 | B2 |
10967183 | Yakovlev et al. | Apr 2021 | B2 |
11007364 | Carroll | May 2021 | B2 |
11027126 | Ackermann et al. | Jun 2021 | B2 |
11071863 | Torgerson | Jul 2021 | B2 |
11116965 | Snyder | Sep 2021 | B2 |
11116975 | Oron et al. | Sep 2021 | B2 |
11167129 | Parker | Nov 2021 | B2 |
11235146 | Boggs et al. | Feb 2022 | B2 |
11247053 | Rajguru et al. | Feb 2022 | B2 |
11253705 | John | Feb 2022 | B1 |
11278718 | Faltys et al. | Mar 2022 | B2 |
11311726 | Vansickle et al. | Apr 2022 | B2 |
11331489 | Johanek | May 2022 | B2 |
11331493 | Pivonka et al. | May 2022 | B2 |
11344726 | Bennett et al. | May 2022 | B2 |
11344729 | Single et al. | May 2022 | B1 |
20020055779 | Andrews | May 2002 | A1 |
20020198572 | Weiner | Dec 2002 | A1 |
20030144709 | Zabara et al. | Jul 2003 | A1 |
20040015295 | Whitehurst et al. | Jan 2004 | A1 |
20040111139 | McCreery | Jun 2004 | A1 |
20040147977 | Petrofsky | Jul 2004 | A1 |
20040243182 | Cohen et al. | Dec 2004 | A1 |
20050131485 | Knudson et al. | Jun 2005 | A1 |
20050137648 | Cosendai et al. | Jun 2005 | A1 |
20050143789 | Whitehurst et al. | Jun 2005 | A1 |
20050149148 | King | Jul 2005 | A1 |
20050149154 | Cohen et al. | Jul 2005 | A1 |
20060025832 | O'Keeffe et al. | Feb 2006 | A1 |
20060030919 | Mrva et al. | Feb 2006 | A1 |
20060184211 | Gaunt et al. | Aug 2006 | A1 |
20060195158 | Cory | Aug 2006 | A1 |
20060270944 | King et al. | Nov 2006 | A1 |
20060271137 | Stanton-Hicks | Nov 2006 | A1 |
20060293721 | Tarver et al. | Dec 2006 | A1 |
20070043400 | Donders | Feb 2007 | A1 |
20070142863 | Bradley | Jun 2007 | A1 |
20070185549 | Zdeblick | Aug 2007 | A1 |
20080027505 | Levin et al. | Jan 2008 | A1 |
20080046055 | Durand et al. | Feb 2008 | A1 |
20080086180 | Ben-Ezra et al. | Apr 2008 | A1 |
20080172116 | Mrva | Jul 2008 | A1 |
20080183226 | Buras et al. | Jul 2008 | A1 |
20080228194 | Westlund | Sep 2008 | A1 |
20080319511 | Pless | Dec 2008 | A1 |
20090069738 | Rossing et al. | Mar 2009 | A1 |
20090083070 | Giftakis et al. | Mar 2009 | A1 |
20090204173 | Fang et al. | Aug 2009 | A1 |
20090281595 | King et al. | Nov 2009 | A1 |
20100121408 | Imran et al. | May 2010 | A1 |
20100152808 | Boggs, II | Jun 2010 | A1 |
20100168820 | Maniak et al. | Jul 2010 | A1 |
20100211135 | Caparso et al. | Aug 2010 | A1 |
20100274312 | Alataris et al. | Oct 2010 | A1 |
20100274314 | Alataris et al. | Oct 2010 | A1 |
20100274315 | Alataris et al. | Oct 2010 | A1 |
20100274316 | Alataris et al. | Oct 2010 | A1 |
20100274317 | Parker et al. | Oct 2010 | A1 |
20100274318 | Walker et al. | Oct 2010 | A1 |
20100274326 | Chitre et al. | Oct 2010 | A1 |
20110071593 | Parker et al. | Mar 2011 | A1 |
20110230701 | Simon et al. | Sep 2011 | A1 |
20120016439 | Alataris et al. | Jan 2012 | A1 |
20120083709 | Parker et al. | Apr 2012 | A1 |
20120083856 | Thacker et al. | Apr 2012 | A1 |
20120089199 | Bolea et al. | Apr 2012 | A1 |
20120232615 | Barolat et al. | Sep 2012 | A1 |
20120253261 | Poletto et al. | Oct 2012 | A1 |
20130035735 | Kroll | Feb 2013 | A1 |
20130289664 | Johanek | Oct 2013 | A1 |
20130289667 | Wacnik et al. | Oct 2013 | A1 |
20140046398 | Sachs et al. | Feb 2014 | A1 |
20140188186 | Barolat et al. | Jul 2014 | A1 |
20140228905 | Bolea | Aug 2014 | A1 |
20150230809 | Becker | Aug 2015 | A1 |
20160256685 | Haessler | Sep 2016 | A1 |
20160361542 | Kaula et al. | Dec 2016 | A1 |
20170007836 | Nassif | Jan 2017 | A1 |
20170095667 | Yakovlev et al. | Apr 2017 | A1 |
20170239486 | Suryavanshi | Aug 2017 | A1 |
20170319381 | Rogers | Nov 2017 | A1 |
20170333701 | Bradley et al. | Nov 2017 | A1 |
20170348532 | Moffitt et al. | Dec 2017 | A1 |
20180008827 | Dolev et al. | Jan 2018 | A1 |
20180021577 | Phillips | Jan 2018 | A1 |
20180043172 | Serrano Carmona | Feb 2018 | A1 |
20180056066 | Boggs et al. | Mar 2018 | A1 |
20180140835 | Sharma | May 2018 | A1 |
20180333576 | Rigaux | Nov 2018 | A1 |
20190151659 | Mishra et al. | May 2019 | A1 |
20190184170 | Knudson et al. | Jun 2019 | A1 |
20190308020 | Syed Shah et al. | Oct 2019 | A1 |
20190358455 | Lin et al. | Nov 2019 | A1 |
20190358466 | Leung et al. | Nov 2019 | A1 |
20190374779 | Kilgore et al. | Dec 2019 | A1 |
20200391032 | Fang et al. | Dec 2020 | A1 |
20210113840 | Bhadra et al. | Apr 2021 | A1 |
20210154478 | Hincapie Ordonez et al. | May 2021 | A1 |
20210220642 | Fang et al. | Jul 2021 | A1 |
20210236820 | Parker et al. | Aug 2021 | A1 |
20210244952 | Iorio et al. | Aug 2021 | A1 |
20210252288 | Lin et al. | Aug 2021 | A1 |
20210260381 | Kilgore et al. | Aug 2021 | A1 |
20210283398 | Kibler et al. | Sep 2021 | A1 |
20210283401 | Tai | Sep 2021 | A1 |
20210308456 | Gliner et al. | Oct 2021 | A1 |
20220008723 | Hsu et al. | Jan 2022 | A1 |
20220016421 | Boggs et al. | Jan 2022 | A1 |
20220023634 | Parker et al. | Jan 2022 | A1 |
20220023635 | Pepin et al. | Jan 2022 | A1 |
20220023648 | Doan et al. | Jan 2022 | A1 |
20220032060 | Bhadra et al. | Feb 2022 | A1 |
20220152393 | Kent et al. | May 2022 | A1 |
20220176108 | Linden et al. | Jun 2022 | A1 |
20220339446 | Fang et al. | Oct 2022 | A1 |
Number | Date | Country |
---|---|---|
102573986 | Jul 2012 | CN |
202010015346 | Apr 2011 | DE |
3219357 | Sep 2017 | EP |
2009522015 | Jun 2009 | JP |
2012130579 | Jul 2012 | JP |
WO0061222 | Oct 2000 | WO |
WO2005105202 | Nov 2005 | WO |
WO2007117347 | Oct 2007 | WO |
WO2009079270 | Jun 2009 | WO |
WO2012159002 | Nov 2012 | WO |
WO2018033855 | Feb 2018 | WO |
WO2018067239 | Apr 2018 | WO |
WO2018106839 | Jun 2018 | WO |
WO2020041323 | Feb 2020 | WO |
Entry |
---|
Ackermann et al.; Effect of bipolar cuff electrode design on block thresholds in high-frequency electrical neural conduction block; IEEE Transactions on Neural Systems and Rehabilitation Engineering; 17(5); pp. 469-477; Oct. 1, 2009. |
Ackermann et al.; Electrical conduction block in large nerves: high frequency current delivery in the nonhuman primate; Muscle and Nerve. 43(6); pp. 897-899; Jun. 2011. |
Becker et al.; Essentials of local anesthetic pharmacology; Anesthesia progress; 53(3); pp. 98-109; Sep. 2006. |
Bhadra et al.; High-frequency electrical conduction block of mammalian peripheral motor nerve; Muscle and Nerve; 32(6); pp. 782-790; Dec. 2005. |
Bhadra et al.; Simulation of high-frequency sinusoidal electrical block of mammalian myelinated axons: Journal of Computational Neuroscience; 22(3); pp. 313-326; Jun. 1, 2007. |
Bouaziz et al.; Neurologic complication of peripheral neural blockade. In Cousins and Bridenbaugh's Neural blockade in clinical anesthesia and pain medicine, 4th ed. (Cousins et al., eds.); Ch. 20; Lippincott Williams and Wilkins; pp. 464-477: (year of pub sufficiently earlier than effective US filing date and any foreign priority date) 2009. |
Cleeland et al.; Pain assessment: global use of the Brief Pain Inventory; Annals, Academy of Medicine, Singapore; 23(2); pp. 129-138; Mar. 1994. |
Dickinson et al.; Maldynia: pathophysiology and management of neuropathic and maladaptive pain'a report of the AMA Council on Science and Public Health; Pain Medicine; 11(11); pp. 1635-1653; Nov. 1, 2010. |
Dworkin et al.; Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations; The Journal of Pain; 9(2); pp. 105-121; Feb. 1, 2008. |
Fisher et al.; Chronic stability and selectivity of four-contact spiral nerve-cuff electrodes in stimulating the human femoral nerve; J. Neural Eng.; 6(4); pp. 1-16; Aug. 2009. |
Flor et al.; Phantom limb pain: a case of maladaptive CNS plasticity? Nature Reviews Neuroscience; 7(11); pp. 873-881; Nov. 2006. |
Fyfe, N.; An audit of amputation levels in patients referred for prosthetic rehabilitation; Prosthetics and Orthotics International; 14(2); pp. 67-70; Aug. 1990. |
Gerges et al.; Frequency-and amplitude-transitioned waveforms mitigate the onset response in high-frequency nerve block; Journal of Neural Engineering; 7(6); pp. 1-17; Dec. 2010. |
Guse et al.; Outcomes of the surgical treatment of peripheral neuromas of the hand and forearm: a 25-year comparative outcome study; Annals of plastic surgery; 71(6); pp. 654-658; (abstract) Dec. 1, 2013. |
Hadzic et al.; Neurologic complications of peripheral nerve blocks. In Peripheral nerve blocks: principles and practice, 3rd ed. (Hadzic and Vloka, eds.); Ch. 6; New York: McGraw-Hill; pp. 67-77; Sep. 20, 2004. |
Haroutounian et al.; Primary afferent input critical for maintaining spontaneous pain in peripheral neuropathy; Pain; 155(7); pp. 1272-1279 (abstract); Jul. 1, 2014. |
Hsu et al.; Postamputation pain: epidemiology, mechanisms, and treatment; Journal of Pain Research; 6; pp. 121-136; Feb. 12, 2013. |
Keller et al.; Validity of the brief pain inventory for use in documenting the outcomes of patients with noncancer pain; The Clinical Journal of Pain; 20(5); pp. 309-318; Sep. 1, 2004. |
Kilgore et al.; Block of mammalian motor nerve conduction using high frequency alternating current; 10th Annual Conference of International FES Society; Montreal, Canada; pp. 479-481; Jul. 2005. |
Kilgore et al.; Nerve conduction block utilizing high-frequency alternating current; Med. Biol. Eng. Comput.; 42(3); pp. 394-406; May 1, 2004. |
Kilgore et al.; Reversible nerve conduction block using kilohertz frequency alternating current; Neuromodulation: Technology at the Neural Interface; 17(3); pp. 242-255; Apr. 2014. |
Kumar et al.; Spinal cord stimulation versus conventional medical management for neuropathic pain: A multicentre randomised controlled trial in patients with failed back surgery syndrome; Pain; 132(1-2); pp. 179-188; Nov. 1, 2007. |
Leland et al.; American war and military operations casualties: lists and statistics. Congressional Research Service; CRS Report to Congress; RL32492; pp. 1-30; Feb. 26, 2010. |
Lewin-Kowalik et al.; Prevention and management of painful neuroma; Neurol Med Chir (Tokyo); 46(2); pp. 62-68; Feb. 2006. |
Melzack et al.; Pain mechanisms: a new theory; Science; 150(3699); pp. 971-979; Nov. 19, 1965. |
Miles et al.; Effects of ramped amplitude waveforms on the response of high-frequency mammalian nerve block; Journal of Neural Engineering; 4(4); pp. 390-398; Nov. 12, 2007. |
Naples et al.; A spiral nerve cuff electrode for peripheral nerve stimulation; IEEE Transactions On Biomedical Engineering; 35(11); pp. 905-916; Nov. 1988. |
Narang et al.; Functional capabilities of lower limb amputees; Prosthetics and Orthotics International; 8(1); pp. 43-51; Jan. 1, 1984. |
NLLIC Staff. Fact Sheet. Amputation Statistics by Cause Limb Loss in the United States. Amputee Coalition of America (2008) 2 pages; retrieved from internet site http://www.amputee-coalitionsorg/fact_sheets/amp_stats_cause.pdf; Accessed Aug. 26, 2014; (year of pub sufficiently earlier than effective US filing date and any foreign priority date) 2008. |
North et al.; Spinal cord stimulation versus re-operation in patients with failed back surgery syndrome: an international multicenter randomized controlled trial (Evidence study); Neuromodulation: Technology at the Neural Interface; 14(4); pp. 330-336; Jul. 2011. |
Page et al.; Oral Posters—Intrathecal Drug Delivery for Pain and Spasticity: 2013 1630-1640; Spine; 11 June-004. Effect of intrathecal intermittent boluses and morphine concerntration on the incidence of inflammatory mass in a canine model; International Modulation Society; pp. 272-273; Jun. 11, 2013. |
Pohjolainen et al.; Prosthetic use and functional and social outcome following major lower limb amputation; Prosthetics and Orthotics Intl.; 14(2); pp. 75-79; Jan. 1, 1990. |
Polasek et al.; Stimulation stability and selectivity of chronically implanted multicontact nerve cuff electrodes in the human upper extremity; IEEE Transactions On Neural Systems And Rehabilitation Engineering; 17(5); pp. 428-437; Oct. 2009. |
Saper et al.; Occipital nerve stimulation for the treatment of intractable chronic migraine headache: ONSTIM feasibility study; Cephalalgia; 31(3); pp. 271-285; Feb. 2011. |
Schoppen et al.; Physical, mental, and social predictors of functional outcome in unilateral lower-limb amputees; Arch Phys Med Rehabil; 84(6); pp. 803-811; Jun. 1, 2003. |
Sikka; Facial expression analysis for estimating pain in clinical settings; In Proceedings of the 16th International Conference on Multimodal Interaction; pp. 349-353; Nov. 2014. |
Soin et al.; High-frequency electrical nerve block for post amputation pain: a pilot study; Neuromodulation; 16(5); 9 pages; Sep. 1, 2013. |
Soin et al.; Feasibility study on high-frequency electrical nerve block for amputation pain; Neuromodulation; 14(6); p. 561; Nov. 1, 2011. |
Subedi et al.; Phantom limb pain: mechanisms and treatment approaches; Pain Research and Treatment; Article ID 864605; 8 pages; (year of pub sufficiently earlier than effective US filing date and any foreign priority date) 2011. |
Vaso et al.; Peripheral nervous system origin of phantom limb pain; Pain; 155(7); pp. 1384-1391; Jul. 1, 2014. |
Waataja et al.; Effects of high-frequency alternating current on axonal conduction through the vagus nerve; J. Neural Eng.; 8(5); pp. 1-7; Sep. 15, 2011. |
Ziegler-Graham et al.; Estimating the Prevalence of Limb Loss in the United States: 2005 to 2050; Arch Phys Med Rehabil; 89(3); pp. 422-429; Mar. 1, 2008. |
Syed Shah et al.; U.S. Appl. No. 17/455,392 entitled “Apparatuses and methods for setting an electrical dose,” filed Nov. 17, 2021. |
Number | Date | Country | |
---|---|---|---|
20210370054 A1 | Dec 2021 | US |
Number | Date | Country | |
---|---|---|---|
62598369 | Dec 2017 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 16954049 | US | |
Child | 17444876 | US |